Leading the fight against liver cancer in Sub-Saharan Africa: developing the first multidisciplinary liver tumour board in Tanzania
ecancermedicalscience · 15.09.2025 · 19
DOI: 10.3332/ecancer.2025.1987 ↗Kurz gefasst
Fachartikel in der Zeitschrift ecancermedicalscience, online erschienen am 15.09.2025. Verfasst von Ally H Mwanga und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Muhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Multidisciplinary tumour boards (MTBs) are regular meetings of various specialist physicians and healthcare professionals who reach a consensus on diagnostic or therapeutic next steps in a cancer patient's care. They have been used for cancer care worldwide. The benefits of these MTBs are well established in the treatment of cancer, leading to higher rates of care completion and improved overall survival. The authors of this study set out to launch an MTB specifically for liver cancer in Tanzania. Methodology: In 2023, a multidisciplinary liver tumour board (MLTB) was established at Muhimbili National Hospital in Tanzania. This was designed to promote maximum engagement among medical specialties and international collaborators.
Results
MLTB meetings were held weekly in-person and virtually, where members submit patient cases for review of clinical presentation, imaging, pathology and presumed diagnosis to allow discussion of next steps in diagnosis or treatment. A consensus recommendation is then communicated to the involved departments and the presenting physician proceeds with scheduling the patient for completion of the recommendations.
Conclusion
This MLTB model aims to facilitate a comprehensive multidisciplinary treatment strategy for patients diagnosed with liver cancer. MLTBs are expected to enhance the quality of care provided to patients and promote the utilisation of advanced therapeutic options available in these nations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Muhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
- Muhimbili National Hospital, PO Box 65000, Dar es Salaam, Tanzania.
- Department of Interventional Radiology, Muhimbili National Hospital, PO Box 65000 Dar es Salaam, Tanzania.
- Department of Surgery, University of California Medical Center, 2335 Stockton Blvd, Sacramento, CA 95817, USA.
- UC Davis Center for Global Surgery, 2335 Stockton Blvd, 6th Floor, Sacramento, CA 95817, USA.
- Division of Gastroenterology, Department of Internal Medicine, Muhimbili National Hospital, PO Box 65000, Dar es Salaam, Tanzania.
Zitieren
APA
Mwanga, A. H., Mbuguje, E. M., Justiniano, J., Musa, B., Kivuyo, N., Kitua, D. W., Uiso, E., Swallow, A., Kimambo, E., Naif, A., Mwanakulya, D. B., Pazi, S., Ngaiza, A., Wibonela, S., Shaygi, B., & Gaskill, C. E. (2025). Leading the fight against liver cancer in Sub-Saharan Africa: developing the first multidisciplinary liver tumour board in Tanzania. ecancermedicalscience, 19. https://doi.org/10.3332/ecancer.2025.1987
Vancouver
Mwanga AH, Mbuguje EM, Justiniano J, Musa B, Kivuyo N, Kitua DW, et al. Leading the fight against liver cancer in Sub-Saharan Africa: developing the first multidisciplinary liver tumour board in Tanzania. ecancermedicalscience. 2025;19. doi:10.3332/ecancer.2025.1987
BibTeX
@article{Mwanga2025,
author = {Mwanga, Ally H and Mbuguje, Erick M and Justiniano, Jeanine and Musa, Balowa and Kivuyo, Nashivai and Kitua, Daniel W and Uiso, Eva and Swallow, Andrew and Kimambo, Edith and Naif, Azza and Mwanakulya, Deogratius B and Pazi, Swaleh and Ngaiza, Advera and Wibonela, Seif and Shaygi, Behnam and Gaskill, Cameron E},
title = {Leading the fight against liver cancer in Sub-Saharan Africa: developing the first multidisciplinary liver tumour board in Tanzania},
journal = {ecancermedicalscience},
year = {2025},
volume = {19},
doi = {10.3332/ecancer.2025.1987}
}
EUVIMED